Seres Therapeutics

MCRB • NASDAQ • Stock Fundamentals

Seres Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Richard N. Kender, with a market cap of $61.2M.

Market Cap$61.2M

Employees233.0

CEORichard N. Kender

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 5, 2026 · 1 month 9 days agoQ1 2026

Next EarningsAug 5, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Seres Therapeutics

Seres Therapeutics (MCRB) has a market capitalization of $61.2M and trades on NASDAQ.

Seres Therapeutics has approximately 233 employees.